Tharimmune, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tharimmune, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q3 2024.
  • Tharimmune, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $69.7K, a 179% increase year-over-year.
  • Tharimmune, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $267K.
  • Tharimmune, Inc. annual Nonoperating Income (Expense) for 2023 was $136K.
  • Tharimmune, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.59M, a 259% decline from 2021.
  • Tharimmune, Inc. annual Nonoperating Income (Expense) for 2021 was $1M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $267K $69.7K +$44.8K +179% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $222K $48.4K +$20.7K +74.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $201K $91.2K +$65.1K +249% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $136K $57.4K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $25K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $27.7K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $26.1K +$1.62M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $193K -$1.59M -$809K -103% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 $1M $2.55M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-05-22
Q3 2021 -$312K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$458K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$782K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.